Bharat Biotech Says 'No Wrongdoing' Amid Row Over Brazil Covaxin Deal

Bharat Biotech today emphatically denied any wrongdoing amid a huge controversy in Brazil over a $324 million contract for Covaxin shots, now suspended over allegations of irregularities. In a statement, Bharat Biotech said it had followed a "step-by-step" approach towards contracts and regulatory approvals with Brazil.

from Videos https://ift.tt/3dtfZTE

Comments

Popular posts from this blog

दिल्ली के दंगल में अमित शाह, केजरीवाल के गढ़ में की रैली

India Presents Proof Of Pak Aggression At Briefing

New Look For Delhi's Rajpath